Loading
A phase 3 trial of Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisone and Vincristine in Non-Hodgkin lymphoma, run by University Hospital Muenster, active and no longer recruiting.
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents is a phase 3 interventional study registered as NCT03206671 by University Hospital Muenster, with 650 participants planned, started 2017-08-03 and due to reach its primary completion in 2027-06. Interventions recorded: Rituximab window, Additional doses of Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin hydrochloride, Vindesine Sulfate, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine. Conditions recorded: Mature B-cell Non-Hodgkin Lymphoma.
Linked to the drug Vindesine because the registry names it among its interventions and Non-Hodgkin lymphoma among its conditions. Registry record only: no result has been read by an editor.
Shares Vindesine, Cytarabine, Ifosfamide, Methotrexate and the tag pipeline.
Shares Cytarabine, Prednisone, Dexamethasone, Vincristine and the tag pipeline.
Shares Cytarabine, Methotrexate, Prednisone, Vincristine and the tag pipeline.
Shares Cytarabine, Methotrexate, Prednisone, Dexamethasone and the tag pipeline.
Shares Prednisone, Vincristine, Doxorubicin, Cyclophosphamide and the tag pipeline.
Shares Cytarabine, Methotrexate, Prednisone, Dexamethasone and the tag pipeline.
Shares Cytarabine, Methotrexate, Dexamethasone, Vincristine and the tag pipeline.
Shares Vindesine, Ifosfamide, Vincristine, Etoposide and the tag pipeline.